GVR Report cover Competent Cells Market Size, Share & Trends Report

Competent Cells Market Size, Share & Trends Analysis Report By Type (Chemically competent, Electrocompetent cells and Cloned competent cells), By Application, By End-user, By Region, and Segment Forecasts, 2023 To 2030

  • Report ID: GVR453989
  • Number of Pages: 0
  • Format: Electronic (PDF)
  • Historical Data: ---
  • Industry:

Competent cells are bacterial cells that have been genetically modified or treated to allow for the uptake of exogenous DNA, such as plasmids or genomic DNA. They are commonly used in molecular biology techniques like DNA cloning, where a foreign DNA fragment is inserted into a vector and introduced into competent cells. These cells are then grown in a culture, allowing researchers to study the function of the foreign DNA, produce large amounts of DNA for downstream applications or create genetically modified organisms. In recent years, there have been several advancements in the market for competent cells, including the development of high-efficiency competent cells that take up exogenous DNA at a higher rate and the availability of competent cells that are specific for certain species or strains of bacteria. Companies are also been introducing new products. In January 2020, SGI-DNA introduced VmaxTM X2 Competent Cells, designed to produce two to four times as much soluble protein in half the time compared to traditional methods using E. coli.

The market for competent cells has seen significant growth in recent years, driven by the increasing use of molecular biology techniques in research and industrial settings. These cells are essential tools in these techniques, allowing researchers to introduce exogenous DNA into bacterial cells for the purpose of studying its function or creating genetically modified organisms. Additionally, the growing demand for biotechnology-based products and processes such as drugs, industrial enzymes, and sustainable fuels has also contributed to the increase in demand for competent cells. They are often used in the production of these products as they enable researchers to efficiently introduce and express foreign genes in bacterial cells. Advances in technology have also played a role in driving market demand for competent cells, with companies like Canvax Inc offering specialized products such as BL21 (DE3) Competent Cells.

The market is segmented based on type, application, end user, and region. The type segment includes chemically competent cells, electrocompetent cells, and cloned competent cells. The application segment is divided into cloning, protein expression, mutagenesis, and others. The end-user segment is divided into pharmaceutical and biotechnology companies, Academic and research institutes, and others.

Based on the region, the market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. The competent cells market is primarily dominated by North America and Europe due to the high demand for recombinant products and the large amount of research and innovation in the field of recombinant therapy in these regions. In these countries, technological advancements and regulatory changes have had a significant impact on the market for competent cells. Factors such as the volume of production and consumption, import and export trends, pricing, cost of raw materials, and the value chain of the industry are analyzed to forecast the market trends in individual countries. The competition between global and local brands, as well as the impact of tariffs and trade routes, are also considered in the market forecast for each country.

                                     Competent Cells Market Segmentation




Chemically Competent

Electrocompetent Cells

Cloned Competent Cells



Protein Expression



End user

Pharmaceutical and Biotechnology Companies,

Academic and Research Institute



North America (U.S., Canada),

Europe (Germany, France, Italy, Spain, UK),

Asia Pacific (Japan, China, India, South Korea, Australia),

Latin America (Mexico, Brazil, Argentina),

Middle East & Africa (Saudi Arabia, South Africa, UAE)


The competent cells market is a competitive and dynamic space, with a number of major players vying for a share of the market. Some of the key companies operating in this market include Thermo Fisher Scientific, Agilent Technologies, Merck KGaA, Promega Corporation, Bio-Rad Laboratories, New England Biolabs, Takara Bio Inc., Roche Applied Science, Qiagen, and SGI-DNA (Synthetic Genomics, Inc.). These companies offer a wide range of competent cell products and services, including chemical competent cells, electroporation competent cells, transformation competent cells, and specialized competent cell kits. These companies have established a strong presence in the market through a combination of innovative products, comprehensive service offerings, and a global distribution network.

gvr icn


gvr icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.